Troponin-T is preferable to CPK-MB in the diagnosis of acute myocardial infarction (MI) in all of the following situations, EXCEPT:
**Core Concept**
Troponin-T is a highly sensitive and specific biomarker for cardiac injury, reflecting the release of cardiac muscle proteins into the bloodstream following myocardial infarction (MI). It is a component of the troponin complex, which plays a crucial role in muscle contraction. The use of troponin-T over CPK-MB (creatine phosphokinase-myocardial band) in diagnosing MI has become the preferred approach due to its higher specificity and sensitivity.
**Why the Correct Answer is Right**
Troponin-T is the preferred biomarker in diagnosing acute MI because of its higher specificity and sensitivity compared to CPK-MB. This is attributed to the fact that troponin-T is a cardiac-specific protein, whereas CPK-MB is also found in other tissues, leading to potential false positives. The cardiac isoform of troponin-T is released into the bloodstream within 2-3 hours after MI, making it a reliable marker for early diagnosis. Additionally, troponin-T levels remain elevated for up to 14 days, allowing for accurate assessment of MI severity.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because troponin-T is indeed the preferred biomarker in patients with renal failure, as it is less affected by kidney function compared to CPK-MB.
**Option B:** This option is incorrect because troponin-T is also the preferred biomarker in patients with skeletal muscle injury, as it is more specific to cardiac muscle and less affected by skeletal muscle damage.
**Option C:** This option is incorrect because troponin-T is the preferred biomarker in patients with acute MI who have undergone recent cardiac surgery, as it is less affected by the release of CPK-MB from the surgical site.
**Clinical Pearl / High-Yield Fact**
It is essential to note that troponin-T levels can be elevated in conditions other than MI, such as cardiac trauma, cardiac surgery, and myocarditis. However, in the context of acute MI, troponin-T remains the preferred biomarker due to its high specificity and sensitivity.
**Correct Answer:** D.